Search research articles
Contact Us
Filters
Showing results (571-580 of 623) with videos related to
Page
of 63
Sort By:
Health Policy (Amsterdam, Netherlands)
|
March 28, 2022
Government policies targeting primary care physician practice from 1998-2018 in three Canadian provinces: A jurisdictional scan
Madeleine McKay, M Ruth Lavergne, Amanda Prince Lea, et al.
Diabetologia
|
October 1, 2005
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia
M E Patti, G McMahon, E C Mun, et al.
The American Journal of Emergency Medicine
|
January 7, 2025
POCUS-first in acute diverticulitis: Quantifying cost savings, length-of-stay reduction, and radiation risk mitigation in the ED
Michael F Barton, Kailynn M Barton, Andrew J Goldsmith, et al.
Leukemia & Lymphoma
|
April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma
Sarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.
Nephron. Clinical Practice
|
August 10, 2010
Prevalence and management of anaemia in renal transplant recipients: data from ten European centres
Miklos Zsolt Molnar, Istvan Mucsi, Iain C Macdougall, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 26, 2010
American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer
Seth A Rosenthal, Nathan H J Bittner, David C Beyer, et al.
Cancer
|
December 20, 2005
Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma
Alan D Dosik, Morton Coleman, Lale Kostakoglu, et al.
Cell Metabolism
|
August 7, 2009
PET imaging of leptin biodistribution and metabolism in rodents and primates
Giovanni Ceccarini, Robert R Flavell, Eduardo R Butelman, et al.
Cancer
|
April 24, 2019
Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (<sup>177</sup> Lu-J591) for metastatic castration-resistant prostate cancer
Scott T Tagawa, Shankar Vallabhajosula, Paul J Christos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma
John P Leonard, Morton Coleman, Lale Kostakoglu, et al.
Page
of 63
Search research articles
Search
Showing results (571-580 of 623) with videos related to
Sort By:
Page
of 63
Health Policy (Amsterdam, Netherlands)
|
March 28, 2022
Government policies targeting primary care physician practice from 1998-2018 in three Canadian provinces: A jurisdictional scan
Madeleine McKay, M Ruth Lavergne, Amanda Prince Lea, et al.
Diabetologia
|
October 1, 2005
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia
M E Patti, G McMahon, E C Mun, et al.
The American Journal of Emergency Medicine
|
January 7, 2025
POCUS-first in acute diverticulitis: Quantifying cost savings, length-of-stay reduction, and radiation risk mitigation in the ED
Michael F Barton, Kailynn M Barton, Andrew J Goldsmith, et al.
Leukemia & Lymphoma
|
April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma
Sarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.
Nephron. Clinical Practice
|
August 10, 2010
Prevalence and management of anaemia in renal transplant recipients: data from ten European centres
Miklos Zsolt Molnar, Istvan Mucsi, Iain C Macdougall, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 26, 2010
American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer
Seth A Rosenthal, Nathan H J Bittner, David C Beyer, et al.
Cancer
|
December 20, 2005
Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma
Alan D Dosik, Morton Coleman, Lale Kostakoglu, et al.
Cell Metabolism
|
August 7, 2009
PET imaging of leptin biodistribution and metabolism in rodents and primates
Giovanni Ceccarini, Robert R Flavell, Eduardo R Butelman, et al.
Cancer
|
April 24, 2019
Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (<sup>177</sup> Lu-J591) for metastatic castration-resistant prostate cancer
Scott T Tagawa, Shankar Vallabhajosula, Paul J Christos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma
John P Leonard, Morton Coleman, Lale Kostakoglu, et al.
Page
of 63